Autologous Dendritic Cell Therapy in Mesothelioma Patients Enhances Frequencies of Peripheral CD4 T Cells Expressing HLA-DR, PD-1, or ICOS

Introduction: Malignant pleural mesothelioma (MPM) is a malignancy with a very poor prognosis for which new treatment options are urgently needed. We have previously shown that dendritic cell (DC) immunotherapy provides a clinically feasible treatment option. In the current study, we set out to asse...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Immunol
Autors principals: de Goeje, Pauline L., Klaver, Yarne, Kaijen-Lambers, Margaretha E. H., Langerak, Anton W., Vroman, Heleen, Kunert, André, Lamers, Cor H. J., Aerts, Joachim G. J. V., Debets, Reno, Hendriks, Rudi W.
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2018
Matèries:
Immunology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6137618/
https://ncbi.nlm.nih.gov/pubmed/30245692
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2018.02034
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars